Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update by Robert Roskoski, Jr.

Get full text

Janus kinase (JAK) inhibitors in the treatment of neoplastic and inflammatory disorders by Robert Roskoski, Jr.

Get full text

Cost in the United States of FDA-approved small molecule protein kinase inhibitors used in the treatment of neoplastic and non-neoplastic diseases by Robert Roskoski, Jr.

Get full text

Small molecule protein kinase inhibitors approved by regulatory agencies outside of the United States by Robert Roskoski Jr.

Get full text

Deucravacitinib is an allosteric TYK2 protein kinase inhibitor FDA-approved for the treatment of psoriasis by Robert Roskoski, Jr.

Get full text

Rule of five violations among the FDA-approved small molecule protein kinase inhibitors by Robert Roskoski, Jr.

Get full text

Combination immune checkpoint and targeted protein kinase inhibitors for the treatment of renal cell carcinomas by Robert Roskoski, Jr.

Get full text